Related references
Note: Only part of the references are listed.CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
S. Lefort et al.
ONCOGENE (2017)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
Philippe Gascard et al.
GENES & DEVELOPMENT (2016)
Suppressive activity of human regulatory T cells is maintained in the presence of TNF
Bruno Zaragoza et al.
NATURE MEDICINE (2016)
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
M. R. Mirza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Megan K. Ruhland et al.
NATURE COMMUNICATIONS (2016)
Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through
Luciana Batista et al.
NATURE COMMUNICATIONS (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
Sara Corvigno et al.
ONCOTARGET (2016)
Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment
Tsz-Lun Yeung et al.
BIOMOLECULES (2016)
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary et al.
VACCINES (2016)
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
Keith L. Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
Tina Gruosso et al.
NATURE COMMUNICATIONS (2015)
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
Kim Moran-Jones et al.
ONCOTARGET (2015)
Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset
Gurcan Gunaydin et al.
ONCOIMMUNOLOGY (2015)
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoit Thibault et al.
CANCER AND METASTASIS REVIEWS (2014)
A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer
Dong-Joo Cheon et al.
CLINICAL CANCER RESEARCH (2014)
miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease
Zhen Huang et al.
GUT (2014)
MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis
Stephen R. Filios et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fibroblast heterogeneity in the cancer wound
Daniel Oehlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
Margaret Gil et al.
JOURNAL OF IMMUNOLOGY (2014)
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
Cheng-Fei Liu et al.
PLOS ONE (2014)
The Carcinoma-Associated Fibroblast Expressing Fibroblast Activation Protein and Escape from Immune Surveillance
Douglas T. Fearon
CANCER IMMUNOLOGY RESEARCH (2014)
Clinical Implications of Marker Expression of Carcinoma-Associated Fibroblasts (CAFs) in Patients with Epithelial Ovarian Carcinoma After Treatment with Neoadjuvant Chemotherapy
Paulette Mhawech-Fauceglia et al.
CANCER MICROENVIRONMENT (2014)
Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
Neta Erez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Oncogenes induce the cancer-associated fibroblast phenotype Metabolic symbiosis and fibroblast addiction are new therapeutic targets for drug discovery
Michael P. Lisanti et al.
CELL CYCLE (2013)
Ovarian cancer emerging subtypes: Role of oxidative stress and fibrosis in tumour development and response to treatment
L. Batista et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
M. T. M. van Jaarsveld et al.
ONCOGENE (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
A. Popple et al.
BRITISH JOURNAL OF CANCER (2012)
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Hagen Kulbe et al.
CANCER RESEARCH (2012)
Oxidative Stress Mediated-Alterations of the MicroRNA Expression Profile in Mouse Hippocampal Neurons
Shunjiang Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Song Yi Ko et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
Stefan Bentink et al.
PLOS ONE (2012)
CXCL12 expression by healthy and malignant ovarian epithelial cells
Veronique Machelon et al.
BMC CANCER (2011)
Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
Yuan Zhang et al.
CANCER LETTERS (2011)
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
Elda Righi et al.
CANCER RESEARCH (2011)
miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition
A. Magenta et al.
CELL DEATH AND DIFFERENTIATION (2011)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
Peng Qiu et al.
NATURE BIOTECHNOLOGY (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
Isaiah G. Schauer et al.
NEOPLASIA (2011)
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion
Hongping Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Oxidative stress promotes myofibroblast differentiation and tumour spreading
Aurore Toullec et al.
EMBO MOLECULAR MEDICINE (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Masayuki Shimoda et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Functional diversity of SDF-1 splicing variants
Miroslaw Janowski
CELL ADHESION & MIGRATION (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma
Shuang Wei et al.
CANCER RESEARCH (2007)
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
D. Pils et al.
BRITISH JOURNAL OF CANCER (2007)
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: An independent prognostic factor for tumor progression
Yu-ping Jiang et al.
GYNECOLOGIC ONCOLOGY (2006)
Identification and expression of novel isoforms of human stromal cell-derived factor 1
Lan Yu et al.
GENE (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
